Teva Pharmaceuticals Files 8-K with Financial Updates

Ticker: TEVA · Form: 8-K · Filed: Apr 29, 2026 · CIK: 0000818686

Teva Pharmaceutical Industries Ltd 8-K Filing Summary
FieldDetail
CompanyTeva Pharmaceutical Industries Ltd (TEVA)
Form Type8-K
Filed DateApr 29, 2026
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-results, 8-k, regulation-fd

TL;DR

Teva dropped an 8-K on 4/29/26 - check the press release for the numbers.

AI Summary

On April 29, 2026, TEVA PHARMACEUTICAL INDUSTRIES LTD filed an 8-K report detailing their financial results and other relevant information. The filing includes a press release and exhibits, with specific financial data expected to be disclosed within these documents.

Why It Matters

This filing provides investors with crucial, up-to-date financial information and operational highlights from Teva Pharmaceuticals, impacting investment decisions.

Risk Assessment

Risk Level: low — This is a routine filing of financial results and does not indicate any unusual or significant risks.

Key Players & Entities

  • TEVA PHARMACEUTICAL INDUSTRIES LTD (company) — Filer of the 8-K report
  • 0000818686 (company) — CIK number for TEVA PHARMACEUTICAL INDUSTRIES LTD
  • 2026-04-29 (date) — Filing date and period of report

FAQ

What specific financial results are detailed in the 8-K filing?

The filing indicates Item 2.02 (Results of Operations and Financial Condition) and includes a press release (EX-99.1) and another exhibit (EX-99.2), which would contain the specific financial details.

When was this 8-K report filed and accepted by the SEC?

The 8-K report was filed and accepted on April 29, 2026.

What are the main items disclosed in this 8-K filing?

The main items disclosed are Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits).

What is the business address of TEVA PHARMACEUTICAL INDUSTRIES LTD?

The business address is 124 DVORA HANEVI'A ST., TEL AVIV, Israel.

What is the SIC code for TEVA PHARMACEUTICAL INDUSTRIES LTD?

The SIC code is 2834, which corresponds to Pharmaceutical Preparations.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 29, 2026 regarding TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.